The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract to Medi-Physics, Inc., a subsidiary of General Electric Company, for the provision of radiopharmaceuticals, medical isotopes, and diagnostic imaging agents used in nuclear medicine procedures. The $1,100,000 contract, which is not set aside for small businesses, has an ultimate completion date of July 31, 2025.
Under this FSS contract, Medi-Physics has received multiple firm fixed-price delivery orders from various VA Veterans Integrated Service Networks (VISNs) to supply critical diagnostic imaging products such as DATSCAN (ioflupane I-123), I-123 DATSCAN, and VIZAMYL. These radiopharmaceuticals are used in positron emission tomography (PET) scans and single-photon emission computed tomography (SPECT) imaging to diagnose neurological conditions like Parkinson's disease for veterans and active-duty military personnel receiving care at VA medical centers and military treatment facilities. In addition to the delivery orders, Medi-Physics holds several significant Blanket Purchase Agreements (BPAs) with VA networks and the Defense Health Agency, valued up to $1.76 million, to facilitate the streamlined procurement of these specialized pharmaceutical products.
Generated 12/19/24, 9:08 AM